omnaris
chiesi new zealand limited t/a emerge health - ciclesonide 50ug (per actuation) - nasal spray solution - 50 mcg/dose - active: ciclesonide 50ug (per actuation) excipient: carmellose sodium disodium edetate hydrochloric acid hypromellose microcrystalline cellulose nitrogen potassium sorbate purified water - omnaris® nasal spray is indicated for the treatment of seasonal allergic rhinitis in adults and children 6 years of age and older.
alvesco 160 inhaler
waymade healthcare plc - ciclesonide - pressurised inhalation - 160microgram/1dose
alvesco 160 inhaler
cst pharma ltd - ciclesonide - pressurised inhalation - 160microgram/1dose
aservo equihaler
boehringer ingelheim animal health australia pty. ltd. - ciclesonide - inhalation solution - ciclesonide active 30.0 mg/ml - endocrine system
ciclovent 80
cipla medpro (pty) ltd - ciclesonide - metered dose inhaler - each actuation delivers ciclesonide 80 ?g
ciclovent 160
cipla medpro (pty) ltd - ciclesonide - metered dose inhaler - each actuation delivers ciclesonide 160 ?g
omnair
nycomed (pty) ltd - ciclesonide - nasal spray - each actuation delivers; ciclesonide 50,0 mcg
alvesco 80
agis commercial agency (1989) - ciclesonide 80 mcg - solution for inhalation - ciclesonide - treatment to control persistent asthma in adults and adolescents ( 12 years and older) .
alvesco 160
agis commercial agency (1989) - ciclesonide 160 mcg - solution for inhalation - ciclesonide - treatment to control persistent asthma in adults and adolescents ( 12 years and older) .
omnaris 50 mcg/actuation suspension for inhalation (nasal spray)
astrazeneca pharmaceuticals (phils.), inc.; distributor: zuellig pharma corporation - ciclesonide - suspension for inhalation (nasal spray) - 50 mcg/actuation